Cargando…
N-Glycosylation Modification of Plant-Derived Virus-Like Particles: An Application in Vaccines
Plants have been developed as an alternative system to mammalian cells for production of recombinant prophylactic or therapeutic proteins for human and animal use. Effective plant expression systems for recombinant proteins have been established with the optimal combination of gene expression regula...
Autores principales: | Kim, Hyun-Soon, Jeon, Jae-Heung, Lee, Kyung Jin, Ko, Kisung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055563/ https://www.ncbi.nlm.nih.gov/pubmed/24971324 http://dx.doi.org/10.1155/2014/249519 |
Ejemplares similares
-
Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease
por: Youm, Jung Won, et al.
Publicado: (2008) -
Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants
por: Lim, Chae-Yeon, et al.
Publicado: (2015) -
Construction of SARS-CoV-2 virus-like particles in plant
por: Moon, Ki-Beom, et al.
Publicado: (2022) -
Intracellular Reprogramming of Expression, Glycosylation, and Function of a Plant-Derived Antiviral Therapeutic Monoclonal Antibody
por: Lee, Jeong-Hwan, et al.
Publicado: (2013) -
Expression of a Large Single-Chain 13F6 Antibody with Binding Activity against Ebola Virus-Like Particles in a Plant System
por: Lim, Sohee, et al.
Publicado: (2020)